Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts
- 28 October 2016
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 8 (1) , 4-15
Abstract
The vast majority of breast cancers are positive for estrogen receptor (ER) and depend on estrogens for growth. These tumors are treated with a variety of ER-targeted endocrine therapies, although eventual resistance remains a major clinical problem. Other steroid hormone receptors such as progesterone receptor (PR) and androgen receptor (AR) are emerging as additional prospective targets in breast cancer. The fundamental mechanism of action of these steroid receptors in gene regulation has been defined mainly by several breast cancer cell lines that were established in the late 1970s. More recently, breast cancer patient-derived xenografts (PDX) have been developed by multiple groups at institutions in several countries. These new models capture the large degree of heterogeneity between patients and within tumors and promise to advance our understanding of steroid hormone receptor positive breast cancer and endocrine resistance. Unfortunately, steroid hormone receptor positive breast cancers are much more difficult than their receptor negative counterparts to establish into sustainable PDX. Herein we discuss the derivation of steroid hormone receptor positive breast cancer PDX, several pitfalls in their genesis, and their utility in preclinical and translational steroid hormone receptor research.Keywords
Funding Information
- National Institutes of Health (2R01 CA140985)
This publication has 86 references indexed in Scilit:
- Estrogen receptor beta in breast cancerMolecular and Cellular Endocrinology, 2014
- Progress in endocrine approaches to the treatment and prevention of breast cancerMaturitas, 2011
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenograftsBreast Cancer Research and Treatment, 2011
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast CancerCancer Cell, 2011
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health StudyLaboratory Investigation, 2011
- Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sortingJournal of Virological Methods, 2011
- Deconstructing the molecular portraits of breast cancerMolecular Oncology, 2010
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parametersEuropean Journal of Cancer, 1996